Net Worth Advisory Group grew its position in Danaher Corporation (NYSE:DHR – Free Report) by 399.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 4,328 shares of the conglomerate’s stock after purchasing an additional 3,462 shares during the quarter. Net Worth Advisory Group’s holdings in Danaher were worth $917,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Danaher by 4.0% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 94,949 shares of the conglomerate’s stock worth $21,036,000 after acquiring an additional 3,675 shares during the period. Bank of Stockton boosted its stake in Danaher by 6.4% in the 3rd quarter. Bank of Stockton now owns 6,797 shares of the conglomerate’s stock worth $1,506,000 after purchasing an additional 409 shares during the period. CWA Asset Management Group LLC increased its holdings in Danaher by 6.5% during the 3rd quarter. CWA Asset Management Group LLC now owns 2,095 shares of the conglomerate’s stock worth $464,000 after purchasing an additional 128 shares in the last quarter. Smithbridge Asset Management Inc. DE increased its holdings in Danaher by 240.2% during the 3rd quarter. Smithbridge Asset Management Inc. DE now owns 39,387 shares of the conglomerate’s stock worth $8,726,000 after purchasing an additional 27,808 shares in the last quarter. Finally, Value Partners Investments Inc. raised its stake in shares of Danaher by 11.5% in the 3rd quarter. Value Partners Investments Inc. now owns 11,608 shares of the conglomerate’s stock valued at $2,576,000 after purchasing an additional 1,197 shares during the period. 79.05% of the stock is owned by institutional investors.
Danaher Price Performance
Shares of NYSE DHR opened at $224.45 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The business has a 50-day moving average of $214.35 and a 200-day moving average of $196.30. The stock has a market capitalization of $157.78 billion, a price-to-earnings ratio of 39.87, a PEG ratio of 2.88 and a beta of 0.76. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.77 earnings per share. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio is presently 28.42%.
Analyst Upgrades and Downgrades
DHR has been the subject of several recent research reports. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research report on Sunday. Evercore reissued an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Guggenheim upped their price target on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. TD Cowen raised their price target on shares of Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research note on Tuesday, October 13th. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $235.41.
Check Out Our Latest Stock Analysis on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.
The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.
Featured Articles
- Five stocks we like better than Danaher
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
